OneSource Specialty Pharma Ltd updates on cGMP inspection by USFDA

OneSource Specialty Pharma Limited has announced that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Unit 2 Facility of OneSource Specialty Pharma Limited, located at Doddaballapura, 3rd Phase, Industrial Area, Bangalore, from March 20, 2025, to March 28, 2025.

The inspection has concluded with four observations. The Company will respond to these observations comprehensively to FDA within the stipulated time frame.

Shares of Onesource Specialty Pharma Limited was last trading in BSE at Rs. 1748.05 as compared to the previous close of Rs. 1703.80. The total number of shares traded during the day was 5677 in over 907 trades.

The stock hit an intraday high of Rs. 1763.00 and intraday low of 1680.10. The net turnover during the day was Rs. 9826651.00.

Source : Equity Bulls

Keywords

OnesourceSpecialtyPharma INE013P01021 USFDA cGMP Inspection Unit2